Perkembangan Vaksin COVID-19 Produksi Dalam Negeri
Pengembangan vaksin COVID-19 produksi dalam negeri melalui kerja sama dengan BUMN maupun perusahaan swasta terus berjalan, dan diharapkan dapat diedarkan dan digunakan pada 2022.
| ABX | ||
| 2,476.293 | ||
| -232.5030 | -0.0858% | |
| BISNIS-27 | ||
| 341.730 | ||
| -10.8630 | -0.0308% | |
| DBX | ||
| 2,395.747 | ||
| -85.9520 | -0.0346% | |
| ECONOMIC30 | ||
| 67.504 | ||
| -2.7950 | -0.0398% | |
| ESGQKEHATI | ||
| 86.047 | ||
| -2.2140 | -0.0251% | |
| ESGSKEHATI | ||
| 86.267 | ||
| -2.3090 | -0.0261% | |
| I-GRADE | ||
| 119.531 | ||
| -5.0240 | -0.0403% | |
| AUDRP | ||
| 12,574.000 | ||
| 60.2200 | 0.4812% | |
| EURRP | ||
| 20,205.020 | ||
| -47.8500 | -0.2363% | |
| JPYRP | ||
| 114.073 | ||
| 0.0237 | 0.0208% | |
| SINRP | ||
| 14,093.150 | ||
| 10.9400 | 0.0777% | |
| USDRP | ||
| 18,035.000 | ||
| 14.0000 | 0.0777% | |
